{
    "2021-05-21": [
        [
            {
                "time": "2021-05-21",
                "original_text": "泰格医药(03347)因回购注销部分限制性股票注册资本减少至8.7247亿元",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "回购",
                        "注销",
                        "限制性股票",
                        "注册资本"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2021-05",
                "original_text": "重点推荐股票池(2021年5月)",
                "features": {
                    "keywords": [
                        "重点推荐",
                        "股票池",
                        "2021年5月"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2021-05-21",
                "original_text": "泰格医药精彩亮相 2021 DIA中国年会：加速全球化，创新不停歇",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "DIA中国年会",
                        "全球化",
                        "创新"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2021-05-21",
                "original_text": "5月21日晚间重要行业研究汇总(附股)",
                "features": {
                    "keywords": [
                        "5月21日",
                        "晚间",
                        "行业研究",
                        "汇总"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2021-05-21",
                "original_text": "【异动股】泰格医药(03347.HK)涨5.19%",
                "features": {
                    "keywords": [
                        "异动股",
                        "泰格医药",
                        "涨5.19%"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-Q1",
                "original_text": "医药生物行业2020年及2021年一季度业绩综述：2020年营收增速有所下降 2021Q1业绩大幅回升",
                "features": {
                    "keywords": [
                        "医药生物",
                        "2020年",
                        "2021Q1",
                        "营收增速",
                        "业绩回升"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}